[1] Maluccio M,Covey A.Recent progress in understanding,diagnosing,and treating hepatocellular carcinoma［J］.CA Cancer J Clin,2012,62(6):394-399.
[2] Hoshida Y,Villanueva A,Kobayashi M,et al.Gene expression in fixed tissues and outcome in hepatocellular carcinoma［J］.N Engl J Med,2008,359(19):1995-2004.
[3] Liu M,Jiang L,Guan XY.The genetic and epigenetic alterations in human hepatocellular carcinoma:A recent update［J］.Protein Cell,2014,5(9):673-691.
[4] Logie C,Stunnenberg HG.Epigenetic memory:A macrophage perspective［J］.Semin Immunol,2016,28(4):359-367.
[5] Seligson DB,Horvath S,McBrian MA,et al.Global levels of histone modifications predict prognosis in different cancers［J］.Am J Pathol,2009,174(5):1619-1628.
[6] Manuyakorn A,Paulus R,Farrell J,et al.Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma:Results from rtog 9704［J］.J Clin Oncol,2010,28(8):1358-1365.
[7] Seligson DB,Horvath S,Shi T,et al.Global histone modification patterns predict risk of prostate cancer recurrence［J］.Nature,2005,435(7046):1262-1266.
[8] Hamamoto R,Furukawa Y,Morita M,et al.SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells［J］.Nat Cell Biol,2004,6(8):731-740.
[9] Zou JN,Wang SZ,Yang JS,et al.Knockdown of SMYD3 by rna interference down-regulates c-met expression and inhibits cells migration and invasion induced by hgf［J］.Cancer Lett,2009,280(1):78-85.
[10] Wittekind C.Pitfalls in the classification of liver tumors［J］.Pathologe,2006,27(4):289-293.
[11] Kononen J,Bubendorf L,Kallioniemi A,et al.Tissue microarrays for high-throughput molecular profiling of tumor specimens［J］.Nat Med,1998,4(7):844-847.
[12] Camp RL,Dolled-Filhart M,Rimm DL.X-tile:A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization［J］.Clin Cancer Res,2004,10(21):7252-7259.
[13] Ellinger J,Kahl P,Mertens C,et al.Prognostic relevance of global histone h3 lysine 4(h3k4) methylation in renal cell carcinoma［J］.Int J Cancer,2010,127(10):2360-2366.
[14] Schneider AC,Heukamp LC,Rogenhofer S,et al.Global histone h4k20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer［J］.BJU Int,2011,108(8 Pt 2):E290-296.
[15] Zhou X,Sun H,Chen H,et al.Hypoxia induces trimethylated h3 lysine 4 by inhibition of jarid1a demethylase［J］.Cancer Res,2010,70(10):4214-4221.
[16] Chan SL,Wong VW,Qin S,et al.Infection and cancer:The case of hepatitis b［J］.J Clin Oncol,2016,34(1):83-90.
[17] Park SH,Lee SM,Kim YJ,et al.Charm:Discovery of combinatorial chromatin modification patterns in hepatitis b virus x-transformed mouse liver cancer using association rule mining［J］.BMC Bioinformatics,2016,17(Suppl 16):452.
[18] Chen LB,Xu JY,Yang Z,et al.Silencing SMYD3 in hepatoma demethylates BIZI promoter induces apoptosis and inhibits cell proliferation and migration［J］.World J Gastroenterol,2007,13(43):5718-5724.
[19] Magerl C,Ellinger J,Braunschweig T,et al.H3k4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase ash2 and the demethylase ISD1［J］.Hum Pathol,2010,41(2):181-189.
[20] Horwitz GA,Zhang K,McBrian MA,et al.Adenovirus small EIA alters global patterns of histone modification［J］.Science,2008,321(5892):1084-1085.
[21] Rufiange A,Jacques PE,Bhat W,et al.Genome-wide replication-independent histone h3 exchange occurs predominantly at promoters and implicates h3k56 acetylation and ASF1［J］.Mol Cell,2007,27(3):393-405.
[22]Xiaoli Zheng.Study on mechanism of epigenetic revesion of OCT2 inhibition and sensitization of renal cell carcinoma to oxalipatin［D］.Zhejiang Univesity,2017.